⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15132953 | 0.89 | CYP2C19 (0.34) | — | |
| SCHEMBL6752945 | 0.87 | CYP2C19 (0.38) | — | |
| SCHEMBL1106749 | 0.79 | FFAR3 (0.36) | — | |
| SCHEMBL598110 | 0.77 | — | — | |
| SCHEMBL598045 | 0.76 | — | — | |
| SCHEMBL17110226 | 0.75 | LMNA (0.33) | — | |
| SCHEMBL7002732 | 0.74 | — | — | |
| SCHEMBL3997774 | 0.74 | — | — | |
| SCHEMBL15460034 | 0.73 | ALDH1A1 (0.37) | — | |
| SCHEMBL10615458 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12133839-B2 | Cannabinoid derivatives and methods for their preparation | HEANEY JOHN (US) | 2024-11-05 | — | — | US | disclosed |
| US-11419845-B2 | Cannabinoid derivatives and methods for their preparation | HEANEY JOHN (US) | 2022-08-23 | — | — | US | disclosed |
| US-20220233497-A1 | CANNABINOID DERIVATIVES AND METHODS FOR THEIR PREPARATION | HEANEY JOHN (US) | 2022-07-28 | — | — | US | disclosed |
| WO-2020123250-A1 | CANNABINOID DERIVATIVES AND METHODS FOR THEIR PREPARATION | HEANEY JOHN (US) | 2020-06-18 | — | — | WO | disclosed |
| US-20200179330-A1 | CANNABINOID DERIVATIVES AND METHODS FOR THEIR PREPARATION | HEANEY JOHN (US) | 2020-06-11 | — | — | US | disclosed |
| US-9914702-B2 | Amine derivatives as potassium channel blockers | BIONOMICS LIMITED (AU) | 2018-03-13 | — | — | US | disclosed |
| US-20170088519-A1 | AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS | BIONOMICS, LTD (AU) | 2017-03-30 | — | — | US | disclosed |
| US-9493451-B2 | Amine derivatives as potassium channel blockers | BIONOMICS LIMITED (AU) | 2016-11-15 | — | — | US | disclosed |
| US-9186361-B2 | Compounds and compositions for the treatment of parasitic diseases | NOVARTIS AG (CH) | 2015-11-17 | — | — | US | disclosed |
| US-20150150819-A1 | COMPOSITIONS CONTAINING OPIOID ANTAGONISTS | MERCK SHARP & DOHME CORP. | 2015-06-04 | — | — | US | disclosed |
| WO-2004112704-A2 | SUBSTITUTED PIPERIDINE COMPOUNDS AND METHODS OF THEIR USE | ADOLOR CORPORATION (US) | 2004-12-29 | — | — | WO | disclosed |
| US-20040254218-A1 | Substituted piperidine compounds and methods of their use | CUBIST PHARMACEUTICALS, INC. | 2004-12-16 | — | — | US | disclosed |
| US-20040254156-A1 | Sulfonylamino phenylacetamide derivatives and methods of their use | CALIXA THERAPEUTICS, INC. | 2004-12-16 | — | — | US | disclosed |
| WO-2004101508-A2 | SYNTHETIC TECHNIQUES AND INTERMEDIATES FOR POLYHYDROXY DIENYL LACTONES AND MIMICS THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004093796-A2 | LACTAM DERIVATIVES AND METHODS OF THEIR USE | ADOLOR CORPORATION (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040209857-A1 | Lactam derivatives and methods of their use | ADOLOR CORPORATION | 2004-10-21 | — | — | US | disclosed |
| WO-2004082623-A2 | SUBSTITUTED PIPERIDINE COMPOUNDS | ADOLOR CORPORATION (US) | 2004-09-30 | — | — | WO | disclosed |
| US-20040186135-A1 | Substituted piperidine compounds | CUBIST PHARMACEUTICALS, INC. | 2004-09-23 | — | — | US | disclosed |
| US-20040116428-A1 | Biguanide and dihydrotriazine derivatives | JACOBUS PHARMACEUTICAL COMPANY, INC. | 2004-06-17 | — | — | US | disclosed |
| WO-2004048320-A1 | BIGUANIDE AND DIHYDROTRIAZINE DERIVATIVES | JACOBUS PHARMACEUTICAL COMPANY, INC. (US) | 2004-06-10 | — | — | WO | disclosed |